22+ min ago   (229+ words) August 31, 2026 | Monday | News TSY-110 is being co-developed by Formosa Pharmaceuticals and EirGenix as a biosimilar to Roche’s Kadcyla. The reference therapy is used in HER2-positive metastatic and early-stage breast cancer. The planned pivotal study has been designed following regulatory guidance…...

5+ day, 18+ hour ago   (174+ words) August 25, 2026 | Tuesday | News A mobile clinic has been launched as part of an initiative of The University of Queensland (UQ) and the Australian Cancer Research Foundation (ACRF) that aims to trial state-of-the-art technology such as low-dose CT scanning and AI-enabled…...

1+ week, 2+ day ago   (134+ words) BioSpectrum Asia US-Japan collaboration for liquid biopsy screening in lung cancer August 21, 2026 | Friday | News oncoReveal® Essential+ validated at LSI Medience for cfDNA/cfRNA screening in the LC-SCRUM-Asia project, with testing planned to begin in August 2026 US-based Pillar Biosciences, Inc., LC-SCRUM-Asia…...

1+ week, 2+ day ago   (139+ words) August 21, 2026 | Friday | News South Korea-based Crescom, a company specialising in musculoskeletal medical artificial intelligence (AI), has signed a joint research agreement with the Faculty of Medicine at the National University of Malaysia (UKM) to verify the accuracy of its bone…...

1+ week, 2+ day ago   (537+ words) August 21, 2026 | Friday | News The Obesity and Metabolic Surgery Society of India and the Endocrine Society of India have issued their first joint consensus on obesity management, calling for the condition to be treated as a chronic disease rather than a…...

1+ week, 3+ day ago   (377+ words) August 20, 2026 | Thursday | News Brown University Health and Arcamyra Therapeutics are preparing to launch a Phase I clinical trial of ACM-CpG in patients with peritoneal carcinomatosis following US Food and Drug Administration clearance of Investigational New Drug application 180703. The investigator-initiated BrUOG…...

2+ week, 2+ day ago   (167+ words) August 14, 2026 | Friday | News Manufacturing cell therapies for spinal injuries, malaria vaccine development, and testing medical devices will be the cornerstone of Griffith University’s new Health and Advanced Technology Research and Innovation Centre (HATRIC). A groundbreaking ceremony was recently held as…...

2+ week, 5+ day ago   (467+ words) August 12, 2026 | Wednesday | News L'Oréal Groupe and the NUS Academy for Healthy Longevity at the Yong Loo Lin School of Medicine, National University of Singapore, have launched a multi-year strategic research partnership focused on the role of skin, scalp and hair…...

1+ mon, 1+ week ago   (1617+ words) July 21, 2026 | Tuesday | News Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have developed a swallowable nanoscale delivery platform designed to transport therapeutic enzymes through the stomach’s acidic environment and activate a cancer-killing reaction…...

1+ mon, 1+ week ago   (1609+ words) July 20, 2026 | Monday | News HUYABIO International has reported statistically significant and clinically meaningful topline Phase 3 results for HBI-8000 in combination with nivolumab in advanced melanoma. The global Phase 3 study enrolled 404 patients across 15 countries. It met its primary endpoint, with patients receiving…...